Product Code: GVR-4-68040-113-9
Tissue Clearing Market Summary
The global tissue clearing market size was estimated at USD 131.8 million in 2025 and is projected to grow from USD 143.8 million in 2026 to USD 275.5 million by 2033, at a CAGR of 9.7% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 46.3% in 2025. Market growth is driven by the increasing adoption of advanced 3D imaging techniques, rising demand for neuroscience and oncology research, and expanding applications in preclinical and translational studies.
Global Tissue Clearing Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global tissue clearing market report based on product, tissue, application, end use, and region:
- Product Outlook (Revenue, USD Million, 2021 - 2033)
- Instruments
- Kits & Reagents
- Services
- Tissue Outlook (Revenue, USD Million, 2021 - 2033)
- Soft Tissue
- Hard Tissue
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Neurology
- Oncology
- Cardiology
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Academic Research
- Industrial
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- Thailand
- South Korea
- Latin America
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Product Segment
- 1.1.1.2. Tissue Segment
- 1.1.1.3. Application Segment
- 1.1.1.4. End Use Segment
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objectives
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.9.2. List of Secondary Sources
- 1.9.3. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Growing Adoption of 3D Imaging Technologies
- 3.2.1.2. Increasing Cancer and Pathology Research
- 3.2.1.3. Technological Advancements in Tissue Clearing Reagents
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Risk of Tissue Distortion or Fluorescence Signal Loss During Clearing
- 3.2.2.2. Lack of Standardized Tissue Clearing Protocols
- 3.2.3. Market Opportunities Analysis
- 3.2.4. Market Challenges Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTLE Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Social landscape
- 3.3.2.4. Economic landscape
- 3.3.2.5. Legal landscape
Chapter 4. Product Business Analysis
- 4.1. Segment Dashboard
- 4.2. Tissue Clearing Market: Product Movement Analysis
- 4.3. Instruments
- 4.3.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 4.4. Kits & Reagents
- 4.4.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 4.5. Services
- 4.5.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
Chapter 5. Tissue Business Analysis
- 5.1. Segment Dashboard
- 5.2. Tissue Clearing Market: Tissue Movement Analysis
- 5.3. Soft Tissue
- 5.3.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 5.4. Hard Tissue
- 5.4.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
Chapter 6. Application Business Analysis
- 6.1. Segment Dashboard
- 6.2. Tissue Clearing Market: Application Movement Analysis
- 6.3. Neurology
- 6.3.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 6.4. Oncology
- 6.4.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 6.5. Cardiology
- 6.5.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 6.6. Others
- 6.6.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
Chapter 7. End Use Business Analysis
- 7.1. Segment Dashboard
- 7.2. Tissue Clearing Market: End Use Movement Analysis
- 7.3. Academic Research
- 7.3.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
- 7.4. Industrial
- 7.4.1. Market Estimates and Forecast, 2021 - 2033 (USD Million)
Chapter 8. Regional Business Analysis
- 8.1. Tissue Clearing Market Share By Region, 2025 & 2033
- 8.2. North America
- 8.2.1. North America Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.2.2. U.S.
- 8.2.2.1. Key Country Dynamics
- 8.2.2.2. Competitive Scenario
- 8.2.2.3. Regulatory Framework
- 8.2.2.4. U.S. Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.2.3. Canada
- 8.2.3.1. Key Country Dynamics
- 8.2.3.2. Competitive Scenario
- 8.2.3.3. Regulatory Framework
- 8.2.3.4. Canada Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.2.4. Mexico
- 8.2.4.1. Key Country Dynamics
- 8.2.4.2. Competitive Scenario
- 8.2.4.3. Regulatory Framework
- 8.2.4.4. Mexico Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3. Europe
- 8.3.1. Europe Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.2. UK
- 8.3.2.1. Key Country Dynamics
- 8.3.2.2. Competitive Scenario
- 8.3.2.3. Regulatory Framework
- 8.3.2.4. UK Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.3. Germany
- 8.3.3.1. Key Country Dynamics
- 8.3.3.2. Competitive Scenario
- 8.3.3.3. Regulatory Framework
- 8.3.3.4. Germany Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.4. France
- 8.3.4.1. Key Country Dynamics
- 8.3.4.2. Competitive Scenario
- 8.3.4.3. Regulatory Framework
- 8.3.4.4. France Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.5. Italy
- 8.3.5.1. Key Country Dynamics
- 8.3.5.2. Competitive Scenario
- 8.3.5.3. Regulatory Framework
- 8.3.5.4. Italy Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.6. Spain
- 8.3.6.1. Key Country Dynamics
- 8.3.6.2. Competitive Scenario
- 8.3.6.3. Regulatory Framework
- 8.3.6.4. Spain Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.7. Denmark
- 8.3.7.1. Key Country Dynamics
- 8.3.7.2. Competitive Scenario
- 8.3.7.3. Regulatory Framework
- 8.3.7.4. Denmark Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.8. Sweden
- 8.3.8.1. Key Country Dynamics
- 8.3.8.2. Competitive Scenario
- 8.3.8.3. Regulatory Framework
- 8.3.8.4. Sweden Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.3.9. Norway
- 8.3.9.1. Key Country Dynamics
- 8.3.9.2. Competitive Scenario
- 8.3.9.3. Regulatory Framework
- 8.3.9.4. Norway Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.2. Japan
- 8.4.2.1. Key Country Dynamics
- 8.4.2.2. Competitive Scenario
- 8.4.2.3. Regulatory Framework
- 8.4.2.4. Japan Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.3. China
- 8.4.3.1. Key Country Dynamics
- 8.4.3.2. Competitive Scenario
- 8.4.3.3. Regulatory Framework
- 8.4.3.4. China Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.4. India
- 8.4.4.1. Key Country Dynamics
- 8.4.4.2. Competitive Scenario
- 8.4.4.3. Regulatory Framework
- 8.4.4.4. India Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.5. Australia
- 8.4.5.1. Key Country Dynamics
- 8.4.5.2. Competitive Scenario
- 8.4.5.3. Regulatory Framework
- 8.4.5.4. Australia Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.6. Thailand
- 8.4.6.1. Key Country Dynamics
- 8.4.6.2. Competitive Scenario
- 8.4.6.3. Regulatory Framework
- 8.4.6.4. Thailand Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.4.7. South Korea
- 8.4.7.1. Key Country Dynamics
- 8.4.7.2. Competitive Scenario
- 8.4.7.3. Regulatory Framework
- 8.4.7.4. South Korea Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.5.2. Brazil
- 8.5.2.1. Key Country Dynamics
- 8.5.2.2. Competitive Scenario
- 8.5.2.3. Regulatory Framework
- 8.5.2.4. Brazil Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.5.3. Argentina
- 8.5.3.1. Key Country Dynamics
- 8.5.3.2. Competitive Scenario
- 8.5.3.3. Regulatory Framework
- 8.5.3.4. Argentina Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.6. MEA
- 8.6.1. MEA Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.6.2. South Africa
- 8.6.2.1. Key Country Dynamics
- 8.6.2.2. Competitive Scenario
- 8.6.2.3. Regulatory Framework
- 8.6.2.4. South Africa Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.6.3. Saudi Arabia
- 8.6.3.1. Key Country Dynamics
- 8.6.3.2. Competitive Scenario
- 8.6.3.3. Regulatory Framework
- 8.6.3.4. Saudi Arabia Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.6.4. UAE
- 8.6.4.1. Key Country Dynamics
- 8.6.4.2. Competitive Scenario
- 8.6.4.3. Regulatory Framework
- 8.6.4.4. UAE Tissue Clearing Market, 2021 - 2033 (USD Million)
- 8.6.5. Kuwait
- 8.6.5.1. Key Country Dynamics
- 8.6.5.2. Competitive Scenario
- 8.6.5.3. Regulatory Framework
- 8.6.5.4. Kuwait Tissue Clearing Market, 2021 - 2033 (USD Million)
Chapter 9. Competitive Landscape
- 9.1. Company Categorization
- 9.2. Company Market Share/ Position Analysis, 2025
- 9.3. Strategy Mapping
- 9.4. Company Profiles/Listing
- 9.4.1. Aligned Genetics, Inc. (Formerly Logos Biosystems)
- 9.4.1.1. Overview
- 9.4.1.2. Financial Performance
- 9.4.1.3. Product Benchmarking
- 9.4.1.4. Strategic Initiatives
- 9.4.2. Visikol, Inc.
- 9.4.2.1. Overview
- 9.4.2.2. Financial Performance
- 9.4.2.3. Product Benchmarking
- 9.4.2.4. Strategic Initiatives
- 9.4.3. LifeCanvas Technologies
- 9.4.3.1. Overview
- 9.4.3.2. Financial Performance
- 9.4.3.3. Product Benchmarking
- 9.4.3.4. Strategic Initiatives
- 9.4.4. Miltenyi Biotec
- 9.4.4.1. Overview
- 9.4.4.2. Financial Performance
- 9.4.4.3. Product Benchmarking
- 9.4.4.4. Strategic Initiatives
- 9.4.5. Bio-Techne
- 9.4.5.1. Overview
- 9.4.5.2. Financial Performance
- 9.4.5.3. Product Benchmarking
- 9.4.5.4. Strategic Initiatives
- 9.4.6. Abcam plc
- 9.4.6.1. Overview
- 9.4.6.2. Financial Performance
- 9.4.6.3. Product Benchmarking
- 9.4.6.4. Strategic Initiatives
- 9.4.7. ClearLight Biotechnologies, Inc.
- 9.4.7.1. Overview
- 9.4.7.2. Financial Performance
- 9.4.7.3. Product Benchmarking
- 9.4.7.4. Strategic Initiatives
- 9.4.8. FUJIFILM Corporation
- 9.4.8.1. Overview
- 9.4.8.2. Financial Performance
- 9.4.8.3. Product Benchmarking
- 9.4.8.4. Strategic Initiatives
- 9.4.9. Thermo Fisher Scientific Inc.
- 9.4.9.1. Overview
- 9.4.9.2. Financial Performance
- 9.4.9.3. Product Benchmarking
- 9.4.9.4. Strategic Initiatives
- 9.4.10. Corning Incorporated
- 9.4.10.1. Overview
- 9.4.10.2. Financial Performance
- 9.4.10.3. Product Benchmarking
- 9.4.10.4. Strategic Initiatives
- 9.4.11. Leinco Technologies
- 9.4.11.1. Overview
- 9.4.11.2. Financial Performance
- 9.4.11.3. Product Benchmarking
- 9.4.11.4. Strategic Initiatives